Skip to content
10-Q

Quarterly Report

Immunome, Inc. IMNM

0000950170-25-104035

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 87.05M sh
Shares Diluted Q2 2025 · Jun 30, 2025 87.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 83.23M sh
Shares Diluted Q2 2025 · Jun 30, 2024 59.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.74M sh
Capex Q2 2025 · Jun 30, 2025 $4.57M
Capex Q2 2025 · Jun 30, 2024 $4.51M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$102.46M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$34.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $143.88M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $143.35M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $165.33M
Stockholders Equity Q2 2025 · Jun 30, 2025 $269.27M
Stockholders Equity Q2 2025 · Mar 31, 2025 $307.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 $181.17M
Stockholders Equity Q2 2025 · Jun 30, 2024 $253.84M
Stockholders Equity Q2 2025 · Mar 31, 2024 $285.57M
Stockholders Equity Q2 2025 · Dec 31, 2023 $119.88M
Current Liabilities Q2 2025 · Jun 30, 2025 $22.88M
Current Liabilities Q2 2025 · Dec 31, 2024 $54.31M
Total Liabilities Q2 2025 · Jun 30, 2025 $27.02M
Total Liabilities Q2 2025 · Dec 31, 2024 $59.08M
Current Assets Q2 2025 · Jun 30, 2025 $277.43M
Current Assets Q2 2025 · Dec 31, 2024 $221.34M
Total Assets Q2 2025 · Jun 30, 2025 $296.29M
Total Assets Q2 2025 · Dec 31, 2024 $240.24M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.50
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.60
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.97
Eps Basic Q2 2025 · Jun 30, 2025 −$0.50
Eps Basic Q2 2025 · Jun 30, 2025 −$1.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.60
Eps Basic Q2 2025 · Jun 30, 2024 −$2.97
Sga Expense Q2 2025 · Jun 30, 2025 $10.04M
Sga Expense Q2 2025 · Jun 30, 2025 $20.73M
Sga Expense Q2 2025 · Jun 30, 2024 $6.98M
Sga Expense Q2 2025 · Jun 30, 2024 $12.98M
Rd Expense Q2 2025 · Jun 30, 2025 $40.45M
Rd Expense Q2 2025 · Jun 30, 2025 $77.32M
Rd Expense Q2 2025 · Jun 30, 2024 $29.08M
Rd Expense Q2 2025 · Jun 30, 2024 $44.45M
Net Income Q2 2025 · Jun 30, 2025 −$43.4M
Net Income Q2 2025 · Jun 30, 2025 −$85.04M
Net Income Q2 2025 · Mar 31, 2025 −$41.64M
Net Income Q2 2025 · Jun 30, 2024 −$36.12M
Net Income Q2 2025 · Jun 30, 2024 −$165.61M
Net Income Q2 2025 · Mar 31, 2024 −$129.49M
Operating Income Q2 2025 · Jun 30, 2025 −$46.48M
Operating Income Q2 2025 · Jun 30, 2025 −$91.11M
Operating Income Q2 2025 · Jun 30, 2024 −$40.01M
Operating Income Q2 2025 · Jun 30, 2024 −$172.31M
Revenue Q2 2025 · Jun 30, 2025 $4.02M
Revenue Q2 2025 · Jun 30, 2025 $6.94M
Revenue Q2 2025 · Jun 30, 2024 $2.36M
Revenue Q2 2025 · Jun 30, 2024 $3.39M